Rare Diseases in Neurology — Caring for a Patient with Pompe’s Disease

Introduction. Pompe disease, a severe metabolic myopathy, is caused by mutations in the gene coding for acid alpha-glucosidase (GAA), what lead to intralysosomal accumulation of glycogen in all tissues, most notably in skeletal muscles. Pompe disease was the first documented lysosomal storage diseas...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Roszmann, Mikołaj Hamerski, Marcelina Skrzypek-Czerko
Format: Article
Language:English
Published: Państwowa Akademia Nauk Stosowanych we Włocławku 2019-06-01
Series:Pielęgniarstwo Neurologiczne i Neurochirurgiczne
Subjects:
Online Access:https://apcz.umk.pl/PNIN/article/view/38040
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846128716128714752
author Anna Roszmann
Mikołaj Hamerski
Marcelina Skrzypek-Czerko
author_facet Anna Roszmann
Mikołaj Hamerski
Marcelina Skrzypek-Czerko
author_sort Anna Roszmann
collection DOAJ
description Introduction. Pompe disease, a severe metabolic myopathy, is caused by mutations in the gene coding for acid alpha-glucosidase (GAA), what lead to intralysosomal accumulation of glycogen in all tissues, most notably in skeletal muscles. Pompe disease was the first documented lysosomal storage disease, nowadays we know around 60 similar disorders. Aim. Presentation of the clinical picture of a man with Pompe’s disease. Case Report. A man at the age of 40, diagnosis of the Pompe’s disease was made only at the age of 31. The first symptoms, indicating the patient’s development of the disease, were already present in the early school age. At first, the clinical picture presented by the patient led to the diagnosis of muscular dystrophy. Discussion. Pompe disease presents as a continuum of clinical phenotypes that differ by age of onset, severity, and organ involvement. Pompe disease affects people of all ages with varying degrees of severity. Two main broad types are recognized based on the onset of symptoms and the presence or absence of cardiomyopathy. Infantile onset Pompe disease (IOPD) as one, and the most severe for mod the disease. Other and less destructive is late-onset Pompe disease (LOPD) manifests any time after 12 months of age. The disease can be successfully treated by enzyme replacement therapy with alglucosidase alfa that was approved for human use in 2006. Conclusions. In big importance is nurses role as educators and support for the patients during their hospitalizations for medicine infusions twice a month. It time when the knowledge and significance of proper life style can be discussed and implemented to empower the patients. (JNNN 2019;8(4):170–176)
format Article
id doaj-art-dd62d2ec7c1046fdbb7ba1e979ceab28
institution Kabale University
issn 2084-8021
2299-0321
language English
publishDate 2019-06-01
publisher Państwowa Akademia Nauk Stosowanych we Włocławku
record_format Article
series Pielęgniarstwo Neurologiczne i Neurochirurgiczne
spelling doaj-art-dd62d2ec7c1046fdbb7ba1e979ceab282024-12-10T23:56:35ZengPaństwowa Akademia Nauk Stosowanych we WłocławkuPielęgniarstwo Neurologiczne i Neurochirurgiczne2084-80212299-03212019-06-018417017610.15225/PNN.2019.8.4.533636Rare Diseases in Neurology — Caring for a Patient with Pompe’s DiseaseAnna Roszmann0Mikołaj Hamerski1Marcelina Skrzypek-Czerko2Department of Neurological — Psychiatric Nursing, Medical University of Gdańsk, Poland Ward of Neurology, Copernicus Medical Entity in Gdańsk, PolandClinic of Cardiac Surgery and Vascular Surgery — Intensive Postoperative Surveillance Department, University Clinical Center in Gdańsk, PolandDepartment of Neurological — Psychiatric Nursing, Medical University of Gdańsk, Poland Department and Clinic of Neurology, Medical University of Gdańsk, PolandIntroduction. Pompe disease, a severe metabolic myopathy, is caused by mutations in the gene coding for acid alpha-glucosidase (GAA), what lead to intralysosomal accumulation of glycogen in all tissues, most notably in skeletal muscles. Pompe disease was the first documented lysosomal storage disease, nowadays we know around 60 similar disorders. Aim. Presentation of the clinical picture of a man with Pompe’s disease. Case Report. A man at the age of 40, diagnosis of the Pompe’s disease was made only at the age of 31. The first symptoms, indicating the patient’s development of the disease, were already present in the early school age. At first, the clinical picture presented by the patient led to the diagnosis of muscular dystrophy. Discussion. Pompe disease presents as a continuum of clinical phenotypes that differ by age of onset, severity, and organ involvement. Pompe disease affects people of all ages with varying degrees of severity. Two main broad types are recognized based on the onset of symptoms and the presence or absence of cardiomyopathy. Infantile onset Pompe disease (IOPD) as one, and the most severe for mod the disease. Other and less destructive is late-onset Pompe disease (LOPD) manifests any time after 12 months of age. The disease can be successfully treated by enzyme replacement therapy with alglucosidase alfa that was approved for human use in 2006. Conclusions. In big importance is nurses role as educators and support for the patients during their hospitalizations for medicine infusions twice a month. It time when the knowledge and significance of proper life style can be discussed and implemented to empower the patients. (JNNN 2019;8(4):170–176)https://apcz.umk.pl/PNIN/article/view/38040pompe’s diseasetreatmentdiagnosiscare
spellingShingle Anna Roszmann
Mikołaj Hamerski
Marcelina Skrzypek-Czerko
Rare Diseases in Neurology — Caring for a Patient with Pompe’s Disease
Pielęgniarstwo Neurologiczne i Neurochirurgiczne
pompe’s disease
treatment
diagnosis
care
title Rare Diseases in Neurology — Caring for a Patient with Pompe’s Disease
title_full Rare Diseases in Neurology — Caring for a Patient with Pompe’s Disease
title_fullStr Rare Diseases in Neurology — Caring for a Patient with Pompe’s Disease
title_full_unstemmed Rare Diseases in Neurology — Caring for a Patient with Pompe’s Disease
title_short Rare Diseases in Neurology — Caring for a Patient with Pompe’s Disease
title_sort rare diseases in neurology caring for a patient with pompe s disease
topic pompe’s disease
treatment
diagnosis
care
url https://apcz.umk.pl/PNIN/article/view/38040
work_keys_str_mv AT annaroszmann rarediseasesinneurologycaringforapatientwithpompesdisease
AT mikołajhamerski rarediseasesinneurologycaringforapatientwithpompesdisease
AT marcelinaskrzypekczerko rarediseasesinneurologycaringforapatientwithpompesdisease